BACKGROUND: Of 1174 new human immunodeficiency virus (HIV) cases diagnosed in Philadelphia, Pennsylvania, in 2008, a total of 771 (66%) were among African Americans. Philadelphia recently introduced a citywide rapid HIV testing program in public clinics. METHODS: We conducted a qualitative study among 60 African Americans undergoing rapid HIV testing in one of Philadelphia's public clinics located in a zip code with high HIV incidence. Employing grounded theory, we used semistructured interviews to assess patients' motivations, perceptions, and clinical experiences with rapid HIV testing. Interviews were transcribed and coded; 20% were double coded to enhance reliability. RESULTS: Primary motivations for undergoing rapid HIV testing included: testing during routine clinical care, presenting for care with symptomatic sexually transmitted infections or opportunistic infections, knowing someone living with HIV/ AIDS, and perceiving oneself at risk for HIV. Most patients reported positive experiences with rapid testing and preferred it to conventional testing because it eliminated the need for return visits and decreased anxiety; however, many expressed concerns about accuracy of rapid HIV testing. Barriers to HIV testing among this population included low self-perceived risk, HIV stigma, and reported homophobia in respondents' communities. CONCLUSION: This rapid testing program was acceptable, convenient, and preferred over conventional HIV testing. Providing educational information about rapid and confirmatory HIV testing may further enhance acceptability of rapid HIV testing in this population. Nationwide expansion of rapid HIV testing in public health centers is an important and acceptable means of achieving President Obama's National AIDS Strategy goals of reducing racial disparities in HIV infection and improving linkage to HIV/AIDS treatment and care services.
BACKGROUND: Of 1174 new human immunodeficiency virus (HIV) cases diagnosed in Philadelphia, Pennsylvania, in 2008, a total of 771 (66%) were among African Americans. Philadelphia recently introduced a citywide rapid HIV testing program in public clinics. METHODS: We conducted a qualitative study among 60 African Americans undergoing rapid HIV testing in one of Philadelphia's public clinics located in a zip code with high HIV incidence. Employing grounded theory, we used semistructured interviews to assess patients' motivations, perceptions, and clinical experiences with rapid HIV testing. Interviews were transcribed and coded; 20% were double coded to enhance reliability. RESULTS: Primary motivations for undergoing rapid HIV testing included: testing during routine clinical care, presenting for care with symptomatic sexually transmitted infections or opportunistic infections, knowing someone living with HIV/ AIDS, and perceiving oneself at risk for HIV. Most patients reported positive experiences with rapid testing and preferred it to conventional testing because it eliminated the need for return visits and decreased anxiety; however, many expressed concerns about accuracy of rapid HIV testing. Barriers to HIV testing among this population included low self-perceived risk, HIV stigma, and reported homophobia in respondents' communities. CONCLUSION: This rapid testing program was acceptable, convenient, and preferred over conventional HIV testing. Providing educational information about rapid and confirmatory HIV testing may further enhance acceptability of rapid HIV testing in this population. Nationwide expansion of rapid HIV testing in public health centers is an important and acceptable means of achieving President Obama's National AIDS Strategy goals of reducing racial disparities in HIV infection and improving linkage to HIV/AIDS treatment and care services.
Authors: Freya Spielberg; Bernard M Branson; Gary M Goldbaum; David Lockhart; Ann Kurth; Connie L Celum; Anthony Rossini; Cathy W Critchlow; Robert W Wood Journal: J Acquir Immune Defic Syndr Date: 2003-03-01 Impact factor: 3.731
Authors: Kelly A Gebo; John A Fleishman; Richard Conviser; Erin D Reilly; P Todd Korthuis; Richard D Moore; James Hellinger; Philip Keiser; Haya R Rubin; Lawrence Crane; Fred J Hellinger; W Christopher Mathews Journal: J Acquir Immune Defic Syndr Date: 2005-01-01 Impact factor: 3.731
Authors: H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Anish P Mahajan; Jennifer N Sayles; Vishal A Patel; Robert H Remien; Sharif R Sawires; Daniel J Ortiz; Greg Szekeres; Thomas J Coates Journal: AIDS Date: 2008-08 Impact factor: 4.177
Authors: Amy Nunn; Caitlin Towey; Philip A Chan; Sharon Parker; Emily Nichols; Patrick Oleskey; Annajane Yolken; Julia Harvey; Geetanjoli Banerjee; Thomas Stopka; Stacey Trooskin Journal: Public Health Rep Date: 2016 Jan-Feb Impact factor: 2.792
Authors: Merhawi T Gebrezgi; Daniel E Mauck; Diana M Sheehan; Kristopher P Fennie; Elena Cyrus; Abraham Degarege; Mary Jo Trepka Journal: Public Health Rep Date: 2019-07-31 Impact factor: 2.792
Authors: Laura M Bogart; Kathryn Pitkin Derose; David E Kanouse; Beth Ann Griffin; Beth Ann Grifin; Ann C Haas; Malcolm V Williams Journal: J Urban Health Date: 2015-02 Impact factor: 3.671
Authors: Amy Nunn; Alexandra Cornwall; Gladys Thomas; Pastor Leslie Callahan; Pastor Alyn Waller; Rafiyq Friend; Pastor Jay Broadnax; Timothy Flanigan Journal: Glob Public Health Date: 2013-02-04
Authors: Magdalena Szaflarski; P Neal Ritchey; C Jeffrey Jacobson; Rhys H Williams; Amy Baumann Grau; Karthikeyan Meganathan; Christopher G Ellison; Joel Tsevat Journal: AIDS Behav Date: 2013-06
Authors: Lai Sze Tso; John Best; Rachel Beanland; Meg Doherty; Mellanye Lackey; Qingyan Ma; Brian J Hall; Bin Yang; Joseph D Tucker Journal: AIDS Date: 2016-06-19 Impact factor: 4.177
Authors: Brian J Hall; Ka-Lon Sou; Rachel Beanland; Mellanye Lacky; Lai Sze Tso; Qingyan Ma; Meg Doherty; Joseph D Tucker Journal: AIDS Behav Date: 2017-06